CANCER, THYROID
Clinical trials for CANCER, THYROID explained in plain language.
Never miss a new study
Get alerted when new CANCER, THYROID trials appear
Sign up with your email to follow new studies for CANCER, THYROID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost thyroid cancer treatment in kids and young adults
Disease control Recruiting nowThis study tests whether giving the targeted drug selpercatinib for 6 months before standard radioactive iodine therapy can improve outcomes for children, adolescents, and young adults (ages 2-25) with a specific type of thyroid cancer linked to RET gene fusions. The goal is to s…
Matched conditions: CANCER, THYROID
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo aims to supercharge standard thyroid cancer therapy
Disease control Recruiting nowThis phase 2 trial tests whether giving larotrectinib for 6 months can make thyroid cancer cells more responsive to radioactive iodine therapy. It enrolls 13 children and young adults with a specific genetic change (NTRK fusion) whose cancer has spread to the lungs. The goal is t…
Matched conditions: CANCER, THYROID
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC